Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth - Wikidata - wikimedia - TriplyDB

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

http://www.wikidata.org/entity/Q28484303

about

Schistosome ABC multidrug transporters: From pharmacology to physiology.C-terminus of MUC16 activates Wnt signaling pathway through its interaction with β-catenin to promote tumorigenesis and metastasis.Siamese crocodile bile induces apoptosis in NCI-H1299 human non-small cell lung cancer cells via a mitochondria-mediated intrinsic pathway and inhibits tumorigenesis.

P2860

Q34705514-031CA0B5-C45B-489F-AECC-2D02B4105966 Q37392837-80BD2DCA-241B-4D59-9B9B-4AAC875AD001 Q37720156-6EB1919A-F408-4C20-9963-887D55F77711

P2860

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

http://www.wikidata.org/entity/Q28484303

description

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

article scientifique

@fr

artículu científicu espublizáu en 2012

@ast

scientific article (publication date: 2012)

@en

wetenschappelijk artikel (gepubliceerd in 2012)

@nl

wissenschaftlicher Artikel

@de

наукова стаття, опублікована у 2012

@uk

научная статья

@ru

مقالة علمية (نشرت عام 2012)

@ar

name

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@ast

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@en

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@nl

type

label

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@ast

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@en

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@nl

prefLabel

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@ast

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@en

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@nl

P1433

Q28484303-06D79150-ACDB-4420-9256-E8E865E8E86F

P1476

Q28484303-E5023765-06A2-4539-B321-2DED5949C18F

P2093

Q28484303-592F939A-E3CE-4906-8E81-005CACC06D76

Q28484303-63E5B70C-A104-4A05-B573-466CFC833C53

Q28484303-B0A82E32-0AF8-473B-8347-AC7271A82834

Q28484303-E678556A-6C6D-43B2-96F7-CE99633DB281

P2860

Q28484303-0494F9DF-7C3E-44C3-96ED-C0DBFEB396E7

Q28484303-0CCE703C-0F79-4561-899D-062E5D35DDED

Q28484303-1AE57B28-8FDF-46AD-B09D-4E2ECFA640FD

Q28484303-1B62000B-06A2-4F88-972B-59667ACD5FDE

Q28484303-1CF180DA-1335-40F1-87FE-2F75B711EE7E

Q28484303-1E42BCC3-FBDF-4663-B964-9170C3FC38B4

Q28484303-22D95E27-0ED5-401E-8AEA-3FAFE238CBFC

Q28484303-2DFC623F-1768-4A5B-8B51-0DAD2A65407A

Q28484303-5253F9CC-1703-4D23-9CBA-D3D373513877

Q28484303-56DF0920-9011-4381-A89A-1030FC99F6BC

P304

Q28484303-6E20CA21-7489-4339-94D8-54EC9AB20E7F

P31

Q28484303-116E6D9D-C1DE-4171-893B-6D543DE2A92F

P3181

Q28484303-47207E39-E18C-4C67-8F20-BF10A0E00A10

P356

Q28484303-1E1A58B9-7EAF-4FD3-9501-200C05F4023E

P407

Q28484303-7DA2E222-8845-4B8D-A9BB-59A019347200

P433

Q28484303-B5E56223-C85A-4EE6-88EC-653100FA414C

P478

Q28484303-7194641D-8B93-40EB-A1DD-393F425A713A

P577

Q28484303-15029637-7E17-4F4F-9BFA-D16A1931D703

P5875

Q28484303-89701FD9-A9BD-4BA5-9581-037932653673

P698

Q28484303-DE650AC0-9AD9-4182-8B5D-AF9D1CD91F46

P932

Q28484303-1654E9F4-958C-46CD-B1C2-7DFF87262A67

P3181

P356

JOURNAL.PONE.0051721

P1433

P1476

Praziquantel synergistically enhances paclitaxel efficacy to inhibit cancer cell growth

@en

P2093

Long Yu Hu

http://www.w3.org/2001/XMLSchema#string

Ming-ke Lu

http://www.w3.org/2001/XMLSchema#string

Xiaotong Li

http://www.w3.org/2001/XMLSchema#string

Zhen Hua Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma

Microtubules as a target for anticancer drugs

Mechanisms of cancer drug resistance

Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells.

P304

e51721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4853339

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0051721

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233950249

http://www.w3.org/2001/XMLSchema#string

P698

23251610

http://www.w3.org/2001/XMLSchema#string

P932

3520897

http://www.w3.org/2001/XMLSchema#string